Beijing Chemclin Biotech Co., Ltd.

Beijing Chemclin Biotech Co., Ltd. (Chemclin), a fully-owned subsidiary company of China Diagnostics Medical Corporation, is a leading diagnostic company specialized on development, manufacturing and distribution of In Vitro Diagnostic (IVD) reagents and instruments. The Company headquartered in Beijing, China. Since its inception in 1999, Chemclin has emerged as one of leading diagnostic companies in China and worldwide. The company recently secured a CNY2.00B Private Equity Round investment at 01 August 2018 from notable investors including HighLight Capital, Legend Capital, Matrix Partners China, Ping An Ventures, FTZ Fund, Zhongjin Kangrui Medical Industrial Fund, China Renaissance, and VMS Asset Management. Chemclin's focus on the development and distribution of diagnostic products in the Biotechnology and Health Care industries, coupled with its recent significant investment, positions the company for continued growth and influence in the global diagnostics market.